| Date | Time | Source | Headline | Symbol | Company |
| 01/03/2006 | 4:18PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/29/2005 | 4:29PM | PR Newswire (US) | Amylin Pharmaceuticals Acquires Facility in Ohio to Manufacture Exenatide LAR | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/22/2005 | 7:15AM | PR Newswire (US) | Amylin Recognized for Biotechnology Leadership and Product Innovation | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/21/2005 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals Elects Dr. James Gavin to Board of Directors | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/15/2005 | 4:20PM | PR Newswire (US) | BYETTA Shown to Reduce Blood Sugar Levels When Added to Patients Treated With TZDs | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/10/2005 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Lehman Brothers Small Cap Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/27/2005 | 11:28AM | PR Newswire (US) | MORNING UPDATE: Seven Summits Research Issues Alerts for VZ, BUD, PD, AMLN, and HLT | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/26/2005 | 5:01PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/20/2005 | 7:44PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/30/2005 | 10:45AM | PR Newswire (US) | MORNING UPDATE: Seven Summits Research Issues Alerts for MU, NOVL, KR, TER, and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/28/2005 | 5:16PM | PR Newswire (US) | Amylin Pharmaceuticals Elects Karin Eastham to Board of Directors | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/22/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at UBS Global Life Sciences Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/19/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Appoints Roger Marchetti as Senior Vice President of Human Resources and Corporate Services | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/09/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Bear Stearns Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/02/2005 | 5:38PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Oppenheimer Diabetes Conference, Thomas Weisel Healthcare Tailwinds Conference and Biocentu | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/30/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Public Offering of Common Stock | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/22/2005 | 5:30PM | PR Newswire (US) | Once Weekly Exenatide LAR Well Tolerated and Improved Glucose Control | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/05/2005 | 10:26AM | PR Newswire (US) | MORNING UPDATE: Mankus-Lavelle Group issues alerts for INTC, AMLN, HET, CMX, and DTV | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/04/2005 | 5:01PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Second Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/29/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Second Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/23/2005 | 5:30PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Bear Stearns Boston Biotech Confab and Friedman Billings Ramsey European Investor Conferenc | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/15/2005 | 10:18AM | PR Newswire (US) | MORNING UPDATE: Mankus-Lavelle Group issues alerts for NVDA, AMLN, STX, UNH, and FD | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2005 | 8:15PM | PR Newswire (US) | Long-Term Data on BYETTA(TM) Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People with Type | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2005 | 6:30PM | PR Newswire (US) | Study Shows BYETTA(TM) Improves Blood Sugar Levels as Effectively as Insulin Glargine | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2005 | 5:43PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2005 | 9:00AM | PR Newswire (US) | Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Presentation of 12 Abstracts at the American Diabetes Association Annual Meeting | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/03/2005 | 8:30AM | PR Newswire (US) | Amylin Presents Results From Pramlintide Obesity Program at 14th Annual European Congress on Obesity | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2005 | 8:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders and Presentation | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/13/2005 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Banc of America Securities' Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |